Packaging systems for human recombinant adenovirus to be used in gene therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7105346
SERIAL NO

10125751

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Presented are ways to address the problem of replication competent adenovirus in adenoviral production for use with, for example, gene therapy. Packaging cells having no overlapping sequences with a selected vector are suited for large scale production of recombinant adenoviruses. A system for use with the invention produces replication defective adenovirus. The system includes a primary cell containing a nucleic acid based on or derived from adenovirus and an isolated recombinant nucleic acid molecule for transfer into the primary cell. The isolated recombinant nucleic acid molecule is based on or derived from an adenovirus, has at least one functional encapsidation signal and at least one functional Inverted Terminal Repeat, and lacks overlapping sequences with the nucleic acid of the cell. Otherwise, the overlapping sequences would enable homologous recombination leading to replication competent adenovirus in the primary cell into which the isolated recombinant nucleic acid molecule is to be transferred.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CRUCELL HOLLAND B.V.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bout, Abraham Moerkapelle, NL 84 1459
Fallaux, Frits J Leiderdorp, NL 10 50
Hoeben, Robert C Leiden, NL 12 53
Valerio, Domenico Oegstgeest, NL 34 552
van, der Eb Alex Jan Oegstgeest, NL 10 296

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation